QSPR Modeling of Biopharmaceutical Properties of Hydroxypropyl Methylcellulose (Cellulose Ethers) Tablets Based on Its Degree of Polymerization

AAPS PharmSciTech. 2019 Sep 13;20(8):308. doi: 10.1208/s12249-019-1514-9.

Abstract

Quantitative structure-property relationship (QSPR) approach has been widely used in predicting physicochemical properties of compounds. However, its application in the estimation of formulation properties based on the polymer used in it to achieve desired formulation characteristics is an extremely challenging process. In the present research, predictive QSPR models were developed by correlating the physicochemical properties of varying grades of cellulose ethers (hydroxypropyl methylcellulose, HPMC) with those of nateglinide (NTG) containing tablets (in vitro and in vivo properties). Sustained release tablets of NTG were prepared by using different grades and concentrations of HPMC and subsequently characterized for in vitro as well as in vivo parameters. Further, QSPR models for individual formulation property were developed by correlating the polymeric physicochemical properties with the formulation characteristics. Subsequently, a true external validation method was used to validate the predictability of developed models. The dissolution study indicated Korsmeyer-Peppas as the best fit model following non-Fickian as drug transport mechanism extending the drug release up to 12 h. In vivo studies showed limited absorption of the NTG. Developed QSPR models showed promising validated predictability for formulation characteristics. The applicability of present work in formulation development could significantly reduce the time and cost expenditure on design trials without actually formulating a delivery system.

Keywords: HPMC; QSPR modeling; biopharmaceutical; degree of polymerization; in vivo.

MeSH terms

  • Animals
  • Computer Simulation
  • Delayed-Action Preparations
  • Drug Compounding
  • Excipients / chemistry*
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacokinetics
  • Hypromellose Derivatives / chemistry*
  • Models, Chemical
  • Nateglinide / administration & dosage
  • Nateglinide / chemistry
  • Nateglinide / pharmacokinetics
  • Polymerization
  • Quantitative Structure-Activity Relationship
  • Rabbits
  • Reproducibility of Results
  • Tablets

Substances

  • Delayed-Action Preparations
  • Excipients
  • Hypoglycemic Agents
  • Tablets
  • Hypromellose Derivatives
  • Nateglinide